EN ES CAT
Aromics
  • Home
  • About
    About us Our Team Funding
  • Research
    Internal R&D Collaborative R&D Partnerships
  • Projects
    Ongoing Projects Finalized Projects
  • Products
    Strategy Pipeline
      Therapeutics Diagnostics
    Publications
  • Careers
  • Newsroom
    News Events Media Downloads
  • Contact

  1. Home
  2. Newsroom
  3. Media

Media

2019

08|2

Using ‘Omics’ to Develop Treatments for Drug-Resistant Cancer

  see details

Using ‘Omics’ to Develop Treatments for Drug-Resistant Cancer

2019

08|26

Copying Asbestos Legacy

  see details

Copying Asbestos Legacy

1919

02|14

AROMICS develops a novel therapy for malignant mesothelioma

  see details

AROMICS develops a novel therapy for malignant mesothelioma

2019

02|14

AROMICS receives 1 Million Euros to advance in its therapy for cancer

  see details

2019

02|14

AROMICS receives 1 Million Euros to advance in its therapy for cancer

  see details

AROMICS receives 1 Million Euros to advance in its therapy for cancer

2018

03|22

AMMIC: New platform for Catalan companies and organizations accelerates drug R&D for minority diseases

  see details

2017

12|18

Asbestos and cancer

  see details

Asbestos and cancer
ACC10
FEDER
Neotec
Enisa
European Commission
Innovative SME
  • Contact
  • Newsroom
  • Web map
©2019 Applied Research using Omics Sciences.
All rights reserved.
Private Area  |  Terms of use  |  Privacy policy